| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $17.03B | — |
| Cost of Revenue | $14.50B | — |
| R&D Expense | $79.0M | — |
| SG&A Expense | $2.91B | — |
| Interest Expense | $94.0M | — |
| Pre-tax Income | -$851.0M | — |
| Income Tax | $524.0M | — |
| Net Income | -$1.37B | — |
| EPS (Basic) | -$6.06 | — |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.85B | -13.4% |
| Accounts Receivable | $1.52B | -32.9% |
| Current Assets | $4.96B | -18.5% |
| Total Assets | $11.46B | -14.7% |
| Current Liabilities | $4.87B | -3.8% |
| Long-term Debt | $3.00B | +0.0% |
| Total Liabilities | $10.00B | -6.8% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $781.0M | — |
| Investing Cash Flow | -$835.0M | — |
| Financing Cash Flow | -$141.0M | — |
| EPS (Diluted) | -$6.06 | — |
| Stockholders' Equity |
| $1.36B |
| -47.9% |